Evidence map›Paper›PMID 27822171›Full record

ArticleEXCLI journal2016

Grape seed powder improves renal failure of chronic kidney disease patients.

Khaoula Turki, Kamel Charradi, Habib Boukhalfa, Monia Belhaj, Ferid Limam, Ezzedine Aouani

Open access · greenAbstract read
In one paragraph

Article in EXCLI journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Antioxidants for adults with chronic kidney disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Promoting Plant-Based Therapies for Chronic Kidney Disease.Journal of evidence-based integrative medicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Khaoula TurkiUniversity of Carthage, Faculty of Sciences of Bizerte, 7021 Jarzouna, Tunisia; Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, 2050 Hammam Lif, Tunisia.
Kamel CharradiUniversity of Carthage, Faculty of Sciences of Bizerte, 7021 Jarzouna, Tunisia; Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, 2050 Hammam Lif, Tunisia.
Habib BoukhalfaHemodialysis Unit, Regional Hospital of Menzel Bourguiba, Tunisia.
Monia BelhajHemodialysis Unit, Habib Bougatfa Hospital, Bizerte, Tunisia.
Ferid LimamLaboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, 2050 Hammam Lif, Tunisia.
Ezzedine AouaniUniversity of Carthage, Faculty of Sciences of Bizerte, 7021 Jarzouna, Tunisia; Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, 2050 Hammam Lif, Tunisia.
Center of Biotechnogy of Borj Cédria · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a syndrome characterized by progressive and irreversible deterioration of renal function linked to slow destruction of renal parenchyma, eventually terminating in death when sufficient number of nephrons are damaged. Oxidative stress is commonly observed in CKD patients resulting from an imbalance between overproduction of reactive oxygen species (ROS) and impairment of defence mechanisms. Grape seed extract (GSE) is a polyphenolic mixture exhibiting antioxidant and anti-inflammatory properties. We conducted an interventional pilot study of supplementation with GSE capsules (GSE group, n = 23) or placebo (control group, n = 10) on CKD patients. Blood and urine samples were collected at baseline and after a six-month-long supplementation period to determine some renal function biomarkers, as well as antioxidant, anti-inflammatory and haematological parameters. GSE improved glomerular filtration rate (GFR) and proteinuria, increased the anti-oxidant status as assessed by high plasma catalase and superoxide dismutase and also lowered lipoperoxidation and carbonylation. GSE ameliorated inflammation by decreasing CRP, triglyceridemia and counteracted anemia and thrombocytopenia. Supplementation with 2 g GSE/day for six months improved some kidney function parameters of CKD patients and this beneficial effect of GSE seems to be mediated at least partly by its antioxidant and anti-inflammatory properties.

Indexed as

antioxidant statuschronic kidney diseasegrape seed extractoxidative stressprotection

Identifiers

PMID27822171
PMCPMC5083963
OpenAlexW2558325187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.